Welcome! This is the NEW free version of the SciBITES Pharma News Engine from SciBite. By using this site you to accept our Terms & Conditions which the use of cookies to enhance your user experience.

Here is the latest news for your query in chronological order, most recent articles at the top. Use the options on the right to filter and customise this news feed.

  Todays Biosimilar (Tag) Articles ...

First Herceptin biosimilar cleared in Europe
http://www.pmlive.com, , 22-Nov-2017
Effectiveness of biosimilar filgrastim vs. original granulocyte colony-stimulating factors in febrile neutropenia prevention in breast cancer patients.
Medline, European journal of clinical pharmacology, 22-Nov-2017
Perspectives on the Current State of the Biosimilar Regulatory Pathway in the United States.
Medline, Clinical pharmacology and therapeutics, 22-Nov-2017
Switching from originator infliximab to biosimilar CT-P13 in real-life: the weight of patient acceptance.
Medline, Joint, bone, spine : revue du rhumatisme, 22-Nov-2017
What is the role of biosimilar G-CSF agents in hematopoietic stem cell mobilization at present?
Medline, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis, 22-Nov-2017
A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled, Dose-finding Study to Evaluate the Efficacy and Safety of IMU-838 for Induction and Maintenance Therapy in Moderate-to-severe Ulcerative Colitis
ClinicalTrials.gov, , 22-Nov-2017
Post-Authorization Safety Study of Remsima® (Infliximab) in Rheumatoid Arthritis Patients in Jordan
ClinicalTrials.gov, , 22-Nov-2017
Samsung Bioepis’ trastuzumab biosimilar gets EC approval for breast cancer
http://regulatoryaffairs.pharmaceutical-business-review.com, , 20-Nov-2017
Samsung Bioepis’ Herceptin biosimilar received final European approval
http://feedproxy.google.com, , 20-Nov-2017

  This Weeks Biosimilar (Tag) Articles ...

Biosimilars Forum Applauds Food and Drug Administration on New Educational Program Promoting Safety and Effectiveness of Biosimilars.
Medline, Rheumatology (Oxford, England), 19-Nov-2017
Coupling of on-column trypsin digestion-peptide mapping and principal component analysis for stability and biosimilarity assessment of recombinant human growth hormone.
Medline, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences [1072] 105-115, 19-Nov-2017
[Switching from one drug therapy to another with the same therapeutic indication without harms.]
Medline, Recenti progressi in medicina [108] 451-453, 19-Nov-2017
Biosimilars: State of Clinical and Regulatory Science.
Medline, Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques [20] 332-348, 19-Nov-2017
Biosimilars in oncology: much ado about nothing?
Medline, Annals of oncology : official journal of the European Society for Medical Oncology, 19-Nov-2017
[Can we transfer the mechanisms of the generics market to biosimilars?]
Medline, Versicherungsmedizin [68] 168-72, 18-Nov-2017
[The importance of biosimilars medicines for private and statutory health insurance].
Medline, Versicherungsmedizin [68] 173-5, 18-Nov-2017
British Biosimilars Association appoints new chair
https://www.europeanpharmaceuticalreview.com, , 15-Nov-2017
New data reinforces clinical basis for switching to Sandoz biosimilar medicines
http://feedproxy.google.com, , 15-Nov-2017
Trastuzumab biosimilar in early breast cancer setting: will there be direct patient benefits?
Medline, Chinese clinical oncology [6] 55, 15-Nov-2017

  Older Biosimilar (Tag) Articles ...

J&J abandons Remicade patent fight against Samsung and its Renflexis biosim
http://www.fiercepharma.com, , 14-Nov-2017
Showing Records 0 ... 20  

The Language Of Science

SciBite provides text-analytics and data intelligence software for drug discovery, clinical and competitor intelligence and much more for pharma, healthcare and life sciences.

This is a Limited, Free Service only touching the surface of how SciBite's tools transform biomedical text, literature, patents, internal documents and news into a rich intelligence network. If you'd like to know more, contact us to see how our tools can transform your work today!

Topic Activity & Tools

Get Daily Alerts!

Click For Email & RSS Alerts


Name: Biosimilar (Tag)
Type: Technology



Must Mention A:

In Context:


Show Most Frequent

Optional, Only Include Source:


[Not available (Why?)]